Residential
Allegiance Rehabilitation Center INC
Allegiance Rehabilitation Center INC was paid $8.22M by Medicaid between Feb 2021 and Apr 2024, across 3 billing codes. Its largest line is H2036, Alcohol and/or other drug treatment program, per diem — 46% of everything it billed.
33Billing provider infoALLEGIANCE REHABILITATION CENTER INC
SIDMAN, PA 15955
SIDMAN, PA 15955
33aNPI1386283299assigned 12/26/2019
33bProvider typeSubstance Abuse Rehabilitation Facility
28Total paid$8.22M
24GClaims3,221
24DCodes billed3
24AFirst – last monthFeb 2021 – Apr 2024
Compared with peers
Next to other Substance Abuse Rehabilitation Facility providers in Pennsylvania
Rank by total paid#23 of 68
Median peer was paid$5.00M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 905 | $2.50M | |
| 2022 | 899 | $2.70M | |
| 2023 | 948 | $2.21M | |
| 2024incomplete | 469 | $818K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H2036 | Alcohol and/or other drug treatment program, per diem | 46% | 1,430 | 857 | $3.81M |
| H0018 | Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem | 40% | 974 | 754 | $3.25M |
| H0013 | Alcohol and/or drug services; acute detoxification (residential addiction program outpatient) | 14% | 817 | 683 | $1.16M |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUFFY, AMANDA (PRESIDENT/CEO)